NORMOXYS, INC.
Industry: Biotechnology (See others in industry)
Address:
300 Market Street
Boston, MA, 02135
Phone: 617-719-9489
Boston, MA, 02135
Phone: 617-719-9489
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2011-11-21 | New | $600,000 | $600,000 | Debt Only | 06 | SEC link |
| 2011-06-23 | New | $1,556,353 | $1,556,353 | Debt Only | 06 | SEC link |
| 2010-05-25 | New | $17,564,384 | $17,564,384 | Equity Only | 06 | SEC link |
| 2010-03-24 | New | $1,050,000 | $1,050,000 | Debt Only | 06 | SEC link |
| 2009-04-29 | New | $4,506,708 | Unknown | Equity Only | SEC link | |
| 2007-08-27 | Paper Filing | Unknown | Unknown | Other | Not Available |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Conrad Bletzer, Jr. | Executive |
| David Clark | Executive |
| Francesco De Rubertis | Director |
| Dr. Jean Pierre Garnier | Director |
| Jean Pierre Garnier | Director |
| Argeris Karabelas | Director |
| Jean Marie Lehn | Director |
| Sara Mckenzie | Executive |
| Claude Nicolau | Director |
| Michele Ollier | Director |
| Martin Tolar | Director, Executive |